Skip to main content
. 2021 Sep 21;185(6):1135–1145. doi: 10.1111/bjd.20595

Figure 2.

Figure 2

Patients achieving improvement in Psoriasis Area and Severity Index (PASI). Proportions of patients achieving (a) ≥ 90% improvement in PASI and (b) 100% improvement in PASI. aBecause of differences in base study lengths, some patients enrolled in LIMMitless earlier than 52 weeks. b675 of the 722 ongoing patients completed the assessment visit at week 172; 47 ongoing patients have reached the assessment window but have not yet completed the assessment visit at week 172. CI, confidence interval; LOCF, last observation carried forward; mNRI, modified nonresponder imputation; OC, observed cases.